Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 55.

Brunello, Eleonora, Bogina, Giuseppe, Bria, Emilio, Vergine, Marco, Zamboni, Giuseppe, Pedron, Serena, Daniele, Isabella, Furlanetto, Jenny, Carbognin, Luisa, Marconi, Marcella, Manfrin, Erminia, Ibrahim, Merdol, Miller, Keith, Tortora, Giampaolo, Molino, Annamaria, Jasani, Bharat, Beccari, Serena, Bonetti, Franco, Chilosi, Marco, Martignoni, Guido and Brunelli, Matteo 2013. The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma. Journal of Cancer Research and Clinical Oncology 139 (9) , pp. 1563-1568. 10.1007/s00432-013-1479-0

Smith, Chris, Fisher, D., Claes, B., Maughan, T. S., Idziaszczyk, Shelley, Peuteman, G., Harris, Rebecca, James, Michelle D., Meade, A., Jasani, Bharat, Adams, Richard A. ORCID:, Kenny, S., Kaplan, R., Lambrechts, D. and Cheadle, Jeremy P. ORCID: 2013. Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab. Clinical Cancer Research 19 (15) , pp. 4104-4113. 10.1158/1078-0432.CCR-12-2581

Eccles, Suzanne A., Aboagye, Eric O., Ali, Simak, Anderson, Annie S., Armes, Jo, Berditchevski, Fedor, Blaydes, Jeremy P., Brennan, Keith, Brown, Nicola J., Bryant, Helen E., Bundred, Nigel J., Burchell, Joy M., Campbell, Anna M., Carroll, Jason S., Clarke, Robert B., Coles, Charlotte E., Cook, Gary J. R., Cox, Angela, Curtin, Nicola J., Dekker, Lodewijk V., dos Santos Silva, Isabel, Duffy, Stephen W., Easton, Douglas F., Eccles, Diana M., Edwards, Dylan R., Edwards, Joanne, Evans, D. Gareth, Fenlon, Deborah F., Flanagan, James M., Foster, Claire, Gallagher, William M., Garcia-Closas, Montserrat, Gee, Julia Margaret Wendy ORCID:, Gescher, Andy J., Goh, Vicky, Groves, Ashley M., Harvey, Amanda J., Harvie, Michelle, Hennessy, Bryan T., Hiscox, Stephen Edward ORCID:, Holen, Ingunn, Howell, Sacha J., Howell, Anthony, Hubbard, Gill, Hulbert-Williams, Nick, Hunter, Myra S., Jasani, Bharat, Jones, Louise J., Key, Timothy J., Kirwan, Cliona C., Kong, Anthony, Kunkler, Ian H., Langdon, Simon P., Leach, Martin O., Mann, David J., Marshall, John F., Martin, Lesley, Martin, Stewart G., Macdougall, Jennifer E., Miles, David W., Miller, William R., Morris, Joanna R., Moss, Sue M., Mullan, Paul, Natrajan, Rachel, O'Connor, James P. B., O'Connor, Rosemary, Palmieri, Carlo, Pharoah, Paul D. P., Rakha, Emad A., Reed, Elizabeth, Robinson, Simon P., Sahai, Erik, Saxton, John M., Schmid, Peter, Smalley, Matthew John ORCID:, Speirs, Valerie, Stein, Robert, Stingl, John, Streuli, Charles H., Tutt, Andrew N. J., Velikova, Galina, Walker, Rosemary A., Watson, Christine J., Williams, Kaye J., Young, Leonie S. and Thompson, Alastair M. 2013. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Research 15 (5) , R92. 10.1186/bcr3493

Schiavon, Beatriz N., Jasani, Bharat, de Brot, Louise, Vassallo, José, Damascena, Aline, Cirullo-Neto, Julio, Ivanildo Neves, José, Augusto Soares, Fernando, Gobbi, Helenice and Malagoli Rocha, Rafael 2012. Evaluation of reliability of FISH versus brightfield dual-probe in situ hybridization (BDISH) for frontline assessment of HER2 status in breast cancer samples in a community setting. The American Journal of Surgical Pathology 36 (10) , pp. 1489-1496. 10.1097/PAS.0b013e3182635987

Kalhan, Atul, Gharibi, Borzo, Vazquez, Marisol, Jasani, Bharat, Neal, James William, Kidd, M., Modlin, I. M., Pfragner, R., Rees, Dafydd Aled ORCID: and Ham, Jack 2012. Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. Purinergic Signalling 8 (2) , pp. 265-274. 10.1007/s11302-011-9280-5

Starczynski, Jane, Atkey, Neil, Connelly, Yvonne, O'Grady, Tony, Campbell, Fiona M., di Palma, Silvana, Wencyk, Peter, Jasani, Bharat, Gandy, Michael and Bartlett, J. M. S. 2012. HER2 gene amplification in breast cancer: a rogues' gallery of challenging diagnostic cases: UKNEQAS interpretation guidelines and research recommendations. American Journal of Clinical Pathology 137 (4) , pp. 595-605. 10.1309/AJCPATBZ2JFN1QQC

Jasani, Bharat and Gibbs, Allen 2012. Mesothelioma not associated with asbestos exposure. Archives of Pathology & Laboratory Medicine 136 (3) , pp. 262-267. 10.5858/arpa.2011-0039-RA

Webster, Richard M., Abraham, Jincy, Palaniappan, Nachiappan, Caley, Andrew, Jasani, Bharat and Barrett-Lee, Peter 2012. Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer network. Do the results of international clinical trials translate into a similar benefit for patients in South East Wales? British Journal of Cancer 106 (1) , pp. 32-38. 10.1038/bjc.2011.506

Chan, David, Campbell, Fiona, Edwards, Paul, Jasani, Bharat, Williams, Geraint Trefor ORCID: and Lewis, Wyn G. 2012. Relative prognostic value of human epidermal growth factor receptor 2 (HER2) expression in operable oesophagogastric cancer. ISRN Surgery 2012 10.5402/2012/804891

Maughan, Timothyn S., Adams, Richard A. ORCID:, Smith, Chris, Meade, Angela M., Seymour, Matthew T., Wilson, Richard H., Idziaszczyk, Shelley A., Harris, Rebecca, Fisher, David, Kenny, Sarah L., Kay, Edward, Mitchell, Jenna K., Madi, Ayman, Jasani, Bharat, James, Michelle D., Bridgewater, John, Kennedy, M. John, Claes, Bart, Lambrechts, Diether, Kaplan, Richard and Cheadle, Jeremy P. ORCID: 2011. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. The Lancet 377 (9783) , pp. 2103-2114. 10.1016/S0140-6736(11)60613-2

Nicholson, Robert Ian, Habashy, H., Gee, Julia Margaret Wendy ORCID:, Finlay, Pauline, Farrow, Lynne, Jasani, Bharat, Barrett-Lee, Peter, Robertson, J. and Ellis, Ieuan ORCID: 2011. Abstract P2-06-19: Transferrin Receptor (CD71) identifies poor response to Tamoxifen in oestrogen receptor positive breast cancer patients [Abstract]. Cancer Research 70 (24 Sup) , P2-P6. 10.1158/0008-5472.SABCS10-P2-06-19

Gee, Julia Margaret Wendy ORCID:, Aleskandarany, M., Finlay, Pauline, Farrow, Lynne, Nicholson, Robert Ian, Habashy, H., Green, Adam, Rakha, E., Powell, D., Jasani, Bharat, Barrett-Lee, Peter, Robertson, J., Shaw, Victoria E. and Ellis, Ieuan ORCID: 2011. Abstract P2-09-37: Immunohistochemical markers progesterone receptor, HER2, Ki67 and bcl-2-Associated Athanogene 1 and prediction of adjuvant Tamoxifen treatment outcome in ER+ early breast cancer [Abstract]. Cancer Research 70 (24 Sup) , P2-09. 10.1158/0008-5472.SABCS10-P2-09-37

Searchfield, Lydia ORCID:, Price, Sally, Betton, Graham, Jasani, Bharat, Riccardi, Daniela ORCID: and Griffiths, David Francis Rees 2011. Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma. Histopathology 58 (2) , pp. 180-190. 10.1111/j.1365-2559.2010.03733.x

Bartlett, J. M. S., Starczynski, J., Atkey, N., Kay, E., O'Grady, A., Gandy, M., Ibrahim, M., Jasani, Bharat, Ellis, I. O., Pinder, S. E. and Walker, R. A. 2011. HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. Journal of Clinical Pathology 64 (8) , pp. 649-653. 10.1136/jcp.2011.089847

Grabellus, Florian, Sheu, Sien-Yi, Tötsch, Martin, Lehmann, Nils, Kaiser, Gernot M., Jasani, Bharat, Taeger, Georg and Schmid, Kurt W. 2010. Overexpression of the drug resistance-associated protein metallothionein does not correlate with response of sarcomas to isolated limb perfusion treatment. Journal of Surgical Oncology 101 (6) , pp. 465-470. 10.1002/jso.21513

Von Ruhland, Christopher John and Jasani, Bharat 2010. The amplification of polymerized diaminobenzidine with physical developers: sensitizing effects of transition metal salts and sulphide. Journal of Microscopy 238 (2) , pp. 111-122. 10.1111/j.1365-2818.2009.03334.x

Webster, Richard, Palaniappan, Nachiappan, Abraham, Jincy, Bertelli, G., Jasani, Bharat and Barrett-Lee, Peter 2010. HER2 Testing, Adjuvant Trastuzumab Use and Results. Our Experience in South Wales [Letter]. Clinical Oncology 22 (10) , p. 894. 10.1016/j.clon.2010.07.003

Joshi, Anurag, Varma, Muralidharan, Wozniak, Sue and Jasani, Bharat 2010. Potential unreliability of normal tissue as positive control in diagnostic immunohistochemistry of poorly differentiated carcinoma. Histopathology 57 (5) , pp. 760-762. 10.1111/j.1365-2559.2010.03692.x

Bartlett, J. M. S., Campbell, F. M., Ibrahim, M., O'Grady, A., Kay, E., Faulkes, C., Collins, N., Starczynski, J., Morgan, John M., Jasani, Bharat and Miller, K. 2010. A UK NEQAS ISH multicenter ring study using the Ventana HER2 dual-color ISH assay. American Journal of Clinical Pathology 135 (1) , pp. 157-162. 10.1309/AJCPVPRKK1ENEDGQ

Mansel, Robert Edward ORCID:, Goyal, Amit, Douglas-Jones, Anthony Gordon, Woods, Victoria, Goyal, Sumit, Monypenny, Ian, Sweetland, Helen Margaret, Newcombe, Robert Gordon ORCID: and Jasani, Bharat 2009. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch™ BLN Assay in the operating room: results of the Cardiff study. Breast Cancer Research and Treatment 115 (3) , pp. 595-600. 10.1007/s10549-008-0155-6

Navabi, Hossein, Jasani, Bharat, Reece, Ann, Clayton, Aled ORCID:, Tabi, Zsuzsanna, Donninger, C., Mason, Malcolm David ORCID: and Adams, Malcolm 2009. A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 27 (1) , pp. 107-115. 10.1016/j.vaccine.2008.10.024

Jasani, Bharat, Gee, Julia Margaret Wendy ORCID:, Hutcheson, Iain Robert, Clarkson, Richard W. E. ORCID:, Bartlett, J. and Barrett-Lee, Peter 2009. Resistance to HER2-directed trastuzumab therapy in breast cancer. Advances in Breast Cancer 6 (3) , pp. 11-18.

Schmitz, Klaus Jürgen, Müller, Carmen Ina, Reis, Henning, Alakus, Hakan, Winde, Günther, Baba, Hideo Andreas, Wohlschlaeger, Jeremias, Jasani, Bharat, Fandrey, Joachim and Schmid, Kurt Werner 2009. Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma. International Journal of Colorectal Disease 24 (11) , pp. 1287-1296. 10.1007/s00384-009-0753-8

Schmitz, Klaus Jūrgen, Lang, Hauke, Kaiser, Gernot, Wohlschlaeger, Jeremias, Sotiropoulos, Georgios Charalambos, Baba, Hideo Andreas, Jasani, Bharat and Schmid, Kurt Werner 2009. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Human Pathology 40 (12) , pp. 1706-1714. 10.1016/j.humpath.2009.01.026

Shousha, S., Peston, D., Amo-Takyi, B., Morgan, M. and Jasani, Bharat 2009. Evaluation of automated silver-enhancedin situhybridization (SISH) for detection ofHER2gene amplification in breast carcinoma excision and core biopsy specimens. Histopathology 54 (2) , pp. 248-253. 10.1111/j.1365-2559.2008.03185.x

Miller, Keith, Barnett, Sarah, O'Grady, Anthony, Campbell, Fiona, Connolly, Yvonne, Kay, Elaine, Ellis, Ian, Morgan, John M., Jasani, Bharat, Ibrahim, Merdol and Bartlett, John M. S. 2009. External quality assurance of HER2 FISH and ISH testing: three years of the uk national external quality assurance scheme. American Journal of Clinical Pathology 131 (1) , pp. 106-111. 10.1309/AJCPLN78ZQXEMNMA

Bartlett, J. M. S., Campbell, F. M., Ibrahim, M., Wencyk, P., Ellis, I., Kay, E., Connolly, Y., O'Grady, A., Di Palma, S., Starczynski, J., Morgan, John M., Jasani, Bharat and Miller, K. 2009. Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISH. American Journal of Clinical Pathology 132 (4) , pp. 514-520. 10.1309/AJCPXY3MJ6GSRCYP

Jeans, Alexander F., Frayling, Ian Martin, Jasani, Bharat, Side, Lucy, Blesing, Claire and Ansorge, Olaf 2009. Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation. Nature Reviews Clinical Oncology 6 (5) , pp. 295-299. 10.1038/nrclinonc.2009.35

Campbell, Lee, Jasani, Bharat, Edwards, K., Gumbleton, Mark ORCID: and Griffiths, David Francis Rees 2008. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. British Journal of Cancer 98 (5) , pp. 931-940. 10.1038/sj.bjc.6604243

Campbell, Lee, Jasani, Bharat, Gumbleton, Mark ORCID:, Edwards, K. and Griffiths, D. F. 2008. Expression of 4EBP1 is an influential prognostic covariate in renal cell carcinoma [Abstract]. Modern Pathology 21 (1s) , 150A. 10.1038/sj.modpathol.3801035

Coleman, Sharon Louise, Gibbs, Allen, Butchart, Eric, Mason, Malcolm David ORCID:, Jasani, Bharat and Tabi, Zsuzsanna 2008. SV40 large T antigen-specific human T cell memory responses. Journal of Medical Virology 80 (8) , pp. 1497-1504. 10.1002/jmv.21216

Walker, R., Bartlett, J. M. S., Dowsett, M., Ellis, I. O., Hanby, A. M., Jasani, Bharat, Miller, K. and Pinder, S. E. 2008. HER2 testing in the UK: further update to recommendations. Journal of Clinical Pathology 61 (7) , pp. 818-824. 10.1136/jcp.2007.054866

Rhodes, A. and Jasani, Bharat 2008. The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact? Journal of Clinical Pathology 62 (1) , pp. 95-96. 10.1136/jcp.2008.060723

Miller, Keith, Jasani, Bharat, Fish, David, Barnett, Sarah, Dodson, Andrew and Ibrahim, Merdol 2008. Potential for false-positive staining with a rabbit monoclonal antibody to progesterone receptor (sp2): findings of the uk national external quality assessment scheme for immunocytochemistry and fish highlight the need for correct validation of antibodies on introduction to the laboratory. American Journal of Clinical Pathology 129 (3) , pp. 398-409. 10.1309/2YXRLEQVPPNRWHGA

Brüggemann, M., White, H., Gaulard, P., Garcia-Sanz, R., Gameiro, P., Oeschger, S., Jasani, Bharat, Ott, M., Delsol, G., Orfao, A., Tiemann, M., Herbst, H., Langerak, A.W., Spaargaren, M., Moreau, E., Groenen, P.J.T.A., Sambade, C., Foroni, L., Carter, G.I., Hummel, M., Bastard, C., Davi, F., Delfau-Larue, M-H, Kneba, M., Dongen, J.J.M. van, Beldjord, K. and Molina, T.J. 2007. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia 21 (2) , pp. 215-221. 10.1038/sj.leu.2404481

Jasani, Bharat, Langerak, A. W., Macintyre, E. A. and Kneba, M. 2007. Improved reliability of lymphoma diagnostics via PCR-based clonal testing: - Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21 (2) , pp. 201-206. 10.1038/sj.leu.2404467

Hughes, Lisa, Palmer-Smith, S., Rogers, M. T., Frayling, Ian Martin, Stephens, M., Rosser, L., Jasani, Bharat, Williams, Geraint ORCID: and Jasani, B. 2006. Investigation of an HNPCC mutation of unknown significance - A clinical and laboratory perspective [Abstract]. Journal of Medical Genetics 43 (Supp.) , S73.

Jasani, Bharat, Douglas-Jones, Anthony Gordon, Rhodes, Anthony, Wozniak, Susan, Barrett-Lee, Peter, Gee, Julia Margaret Wendy ORCID: and Nicholson, Robert Ian 2006. Measurement of estrogen receptor status by immunocytochemistry in paraffin wax sections. Brooks, S. A. and Harris, A., eds. Breast Cancer Research Protocols, Methods in Molecular Medicine, vol. 120. Totowa, NJ: Humana Press, pp. 127-146. (10.1385/1-59259-969-9:127)

Coleman, Sharon Louise, Clayton, Aled ORCID:, Mason, Malcolm David ORCID:, Jasani, Bharat, Adams, Malcolm and Tabi, Zsuzsanna 2005. Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer. Cancer Research 65 (15) , pp. 7000-7006. 10.1158/0008-5472.CAN-04-3792

Coleman, Sharon Louise, Clayton, Aled ORCID:, Mason, Malcolm David ORCID:, Jasani, Bharat, Adams, Malcolm and Tabi, Zsuzsanna 2005. Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer. Cancer Research 65 (15) , pp. 7000-6. 10.1158/0008-5472.CAN-04-3792

Adams, M., Navabi, H., Croston, D., Coleman, Sharon Louise, Tabi, Zsuzsanna, Clayton, Aled ORCID:, Jasani, Bharat and Mason, Malcolm David ORCID: 2005. The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine 23 (17-18) , pp. 2374-2378. 10.1016/j.vaccine.2005.01.014

Navabi, H., Croston, D., Hobot, Jan, Clayton, Aled ORCID:, Zitvogel, L., Jasani, Bharat, Bailey-Wood, R., Wilson, Keith, Tabi, Zsuzsanna, Mason, Malcolm ORCID: and Adams, M. 2005. Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells, Molecules, and Diseases 35 (2) , pp. 149-152. 10.1016/j.bcmd.2005.06.008

Jasani, Bharat, Coleman, Sharon Louise, Butchart, Eric, Evans, Eve M.L., Adams, Malcolm, Mason, Malcolm David ORCID:, Gibbs, Allen and Tabi, Zsuzsanna 2005. Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma. Vaccine 23 (17-18) , pp. 2339-2402. 10.1016/j.vaccine.2005.01.019

Adams, M., Jasani, Bharat, Navabi, H., Man, Stephen Tzekwung ORCID:, Evans, A. S., Donninger, C., Mason, M. and Fiander, Alison Nina 2003. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R). Vaccine 21 (7-8) , pp. 787-90. 10.1016/S0264-410X(02)00599-6

Adams, Malcolm, Borysiewicz, Leszek K., Fiander, Alison Nina, Man, Stephen Tzekwung ORCID:, Jasani, Bharat, Navabi, Hossein, Lipetz, C., Evans, A. S. and Mason, Malcolm David ORCID: 2001. Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine 19 (17-19) , pp. 2549-2556. 10.1016/S0264-410X(00)00488-6

Clayton, Aled ORCID:, Court, Jacquelyn, Navabi, Hossein, Adams, Malcolm, Mason, Malcolm David ORCID:, Hobot, Jan Adam, Newman, Geoff R. and Jasani, Bharat 2001. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. Journal of Immunological Methods 247 (1-2) , pp. 163-174. 10.1016/S0022-1759(00)00321-5

Anstey, Alexander Vincent ORCID:, Marks, Ronald, Long, Colin, Navabi, Hossein, Pearse, Anthony D., Wynford-Thomas, David and Jasani, Bharat 1996. In vivo photoinduction of metallothionein in human skin by ultraviolet irradiation. Journal of Pathology 178 (1) , pp. 84-88. 10.1002/(SICI)1096-9896(199601)178:1<84::AID-PATH430>3.0.CO;2-W

Wallgren-Pettersson, Carina, Jasani, Bharat, Newman, Geoffrey Richard, Morris, Glenn E., Jones, Sally, Singhrao, Sim, Clarke, Angus John ORCID:, Virtanen, Ismo, Holmberg, Christer and Rapola, Juhani 1995. Alpha-actinin in nemaline bodies in congenital nemaline myopathy: immunological confirmation by light and electron microscopy. Neuromuscular Disorders 5 (2) , pp. 93-104. 10.1016/0960-8966(94)00035-8

Anstey, Alexander Vincent ORCID:, Long, Colin C., Navabi, Hossein, Marks, Ronald and Jasani, Bharat 1994. Metallothionein induction by solar-simulated ultraviolet-irradiation of normal skin [Abstract]. Journal of Investigative Dermatology 102 (4) , p. 651. 10.1111/1523-1747.ep12373195

Long, Colin C., Anstey, Alexander Vincent ORCID:, Jasani, Bharat, Navabi, Hossein and Marks, Ronald 1994. The induction of p53 in skin by urv in vivo: no difference between celts and non-celts [Abstract]. Journal of Investigative Dermatology 102 (4) , p. 602. 10.1111/1523-1747.ep12373195

Schmid, K. W., Ellis, I. O., Gee, Julia Margaret Wendy ORCID:, Darke, Barbara M., Lees, W. E., Kay, John, Cryer, Anthony, Stark, J. M., Hittmair, A., Öfner, D., Dünser, M., Margreiter, R., Daxenbichler, G., Nicholson, Robert Ian, Bier, B., Böcker, W. and Jasani, Bharat 1993. Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchovs Archiv 422 (2) , pp. 153-159. 10.1007/BF01607167

Wallgren-Pettersson, Carina, Jasani, Bharat, Rosser, Lyndon G., Lazarou, Lazarus Pavlou, Nicholson, Louise V. B. and Clarke, Angus John ORCID: 1993. Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity. Journal of the Neurological Sciences 118 (1) , pp. 56-63. 10.1016/0022-510X(93)90246-U

Jasani, Bharat, Thomas, N. D., Navabi, H., Millar, David M., Newman, G. R., Gee, Julia Margaret Wendy ORCID: and Williams, E. D. 1992. Dinitrophenyl (DNP) hapten sandwich staining (DHSS) procedure: A 10 year review of its principle reagents and applications. Journal of Immunological Methods 150 (1-2) , pp. 193-198. 10.1016/0022-1759(92)90078-8

Gee, Julia Margaret Wendy ORCID:, Amselgruber, W. M., Jasani, Bharat and Nicholson, Robert Ian 1991. Use of the dinitrophenyl hapten sandwich staining procedure (DHSS) to localize estrogen receptors in paraffin-embedded tissues. Journal of Histochemistry & Cytochemistry 39 (12) , pp. 1659-1670. 10.1177/39.12.1719072

Gee, Julia Margaret Wendy ORCID:, Nicholson, Robert Ian, Jasani, Bharat, Newman, G. R. and Amselgruber, W. M. 1990. An immunocytochemical method for localization of estrogen receptors in rat tissues using a dinitrophenyl (DNP)-labeled rat monoclonal primary antibody. Journal of Histochemistry & Cytochemistry 38 (1) , pp. 69-78. 10.1177/38.1.1688451

This list was generated on Thu Jun 13 09:01:53 2024 BST.